Cargando…

Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?

Neurodegenerative diseases of the central nervous system (CNS) are characterized by progressive neuronal death and neurological dysfunction, leading to increased disability and a loss of cognitive or motor functions. Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis have neu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayne, Katie, White, Jessica A., McMurran, Christopher E., Rivera, Francisco J., de la Fuente, Alerie G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538701/
https://www.ncbi.nlm.nih.gov/pubmed/33173502
http://dx.doi.org/10.3389/fnagi.2020.572090
_version_ 1783590921120514048
author Mayne, Katie
White, Jessica A.
McMurran, Christopher E.
Rivera, Francisco J.
de la Fuente, Alerie G.
author_facet Mayne, Katie
White, Jessica A.
McMurran, Christopher E.
Rivera, Francisco J.
de la Fuente, Alerie G.
author_sort Mayne, Katie
collection PubMed
description Neurodegenerative diseases of the central nervous system (CNS) are characterized by progressive neuronal death and neurological dysfunction, leading to increased disability and a loss of cognitive or motor functions. Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis have neurodegeneration as a primary feature. However, in other CNS diseases such as multiple sclerosis, stroke, traumatic brain injury, and spinal cord injury, neurodegeneration follows another insult, such as demyelination or ischaemia. Although there are different primary causes to these diseases, they all share a hallmark of neuroinflammation. Neuroinflammation can occur through the activation of resident immune cells such as microglia, cells of the innate and adaptive peripheral immune system, meningeal inflammation and autoantibodies directed toward components of the CNS. Despite chronic inflammation being pathogenic in these diseases, local inflammation after insult can also promote endogenous regenerative processes in the CNS, which are key to slowing disease progression. The normal aging process in the healthy brain is associated with a decline in physiological function, a steady increase in levels of neuroinflammation, brain shrinkage, and memory deficits. Likewise, aging is also a key contributor to the progression and exacerbation of neurodegenerative diseases. As there are associated co-morbidities within an aging population, pinpointing the precise relationship between aging and neurodegenerative disease progression can be a challenge. The CNS has historically been considered an isolated, “immune privileged” site, however, there is mounting evidence that adaptive immune cells are present in the CNS of both healthy individuals and diseased patients. Adaptive immune cells have also been implicated in both the degeneration and regeneration of the CNS. In this review, we will discuss the key role of the adaptive immune system in CNS degeneration and regeneration, with a focus on how aging influences this crosstalk.
format Online
Article
Text
id pubmed-7538701
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-75387012020-11-09 Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe? Mayne, Katie White, Jessica A. McMurran, Christopher E. Rivera, Francisco J. de la Fuente, Alerie G. Front Aging Neurosci Neuroscience Neurodegenerative diseases of the central nervous system (CNS) are characterized by progressive neuronal death and neurological dysfunction, leading to increased disability and a loss of cognitive or motor functions. Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis have neurodegeneration as a primary feature. However, in other CNS diseases such as multiple sclerosis, stroke, traumatic brain injury, and spinal cord injury, neurodegeneration follows another insult, such as demyelination or ischaemia. Although there are different primary causes to these diseases, they all share a hallmark of neuroinflammation. Neuroinflammation can occur through the activation of resident immune cells such as microglia, cells of the innate and adaptive peripheral immune system, meningeal inflammation and autoantibodies directed toward components of the CNS. Despite chronic inflammation being pathogenic in these diseases, local inflammation after insult can also promote endogenous regenerative processes in the CNS, which are key to slowing disease progression. The normal aging process in the healthy brain is associated with a decline in physiological function, a steady increase in levels of neuroinflammation, brain shrinkage, and memory deficits. Likewise, aging is also a key contributor to the progression and exacerbation of neurodegenerative diseases. As there are associated co-morbidities within an aging population, pinpointing the precise relationship between aging and neurodegenerative disease progression can be a challenge. The CNS has historically been considered an isolated, “immune privileged” site, however, there is mounting evidence that adaptive immune cells are present in the CNS of both healthy individuals and diseased patients. Adaptive immune cells have also been implicated in both the degeneration and regeneration of the CNS. In this review, we will discuss the key role of the adaptive immune system in CNS degeneration and regeneration, with a focus on how aging influences this crosstalk. Frontiers Media S.A. 2020-09-23 /pmc/articles/PMC7538701/ /pubmed/33173502 http://dx.doi.org/10.3389/fnagi.2020.572090 Text en Copyright © 2020 Mayne, White, McMurran, Rivera and de la Fuente. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Mayne, Katie
White, Jessica A.
McMurran, Christopher E.
Rivera, Francisco J.
de la Fuente, Alerie G.
Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?
title Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?
title_full Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?
title_fullStr Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?
title_full_unstemmed Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?
title_short Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?
title_sort aging and neurodegenerative disease: is the adaptive immune system a friend or foe?
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538701/
https://www.ncbi.nlm.nih.gov/pubmed/33173502
http://dx.doi.org/10.3389/fnagi.2020.572090
work_keys_str_mv AT maynekatie agingandneurodegenerativediseaseistheadaptiveimmunesystemafriendorfoe
AT whitejessicaa agingandneurodegenerativediseaseistheadaptiveimmunesystemafriendorfoe
AT mcmurranchristophere agingandneurodegenerativediseaseistheadaptiveimmunesystemafriendorfoe
AT riverafranciscoj agingandneurodegenerativediseaseistheadaptiveimmunesystemafriendorfoe
AT delafuentealerieg agingandneurodegenerativediseaseistheadaptiveimmunesystemafriendorfoe